TNFSF11 and lung adenocarcinoma: Contrariwise RANKL inhibition in mouse models of lung adenocarcinoma that responded to anti-RANKL agents identified only modest changes in the tumor microenvironment (TME), including the nonspecific depletion of tumor T-cells [73].